# Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells

> **NCT04105582** · PHASE1 · COMPLETED · sponsor: **Universidad Nacional de Colombia** · enrollment: 5 (actual)

## Conditions studied

- Breast Cancer
- Triple Negative Breast Cancer

## Interventions

- **BIOLOGICAL:** Neo-antigen pulsed Dendritic cell

## Key facts

- **NCT ID:** NCT04105582
- **Lead sponsor:** Universidad Nacional de Colombia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2022-02-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2022-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04105582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04105582, "Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04105582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*